From Casetext: Smarter Legal Research

Novartis Pharm. v. Adesanya

United States District Court, E.D. Pennsylvania
Nov 2, 2022
Civil Action 21-3402-KSM (E.D. Pa. Nov. 2, 2022)

Opinion

Civil Action 21-3402-KSM

11-02-2022

NOVARTIS PHARMACEUTICALS, Plaintiff/Appellee, v. ADENEKAN OLA-OLUWA ADESANYA, et al., Defendants/Appellants.


ORDER

KAREN SPENCER MARSTON, J.

AND NOW this 2nd day of November, 2022, upon consideration of Appellants' Initial Brief (Doc. No. 12), Appellee's Response Brief (Doc. No. 15), Appellants' Reply Brief (Doc. No. 20), and the record on appeal (see Doc. Nos. 12-1 through 12-12; Doc. No. 21), it is ORDERED as follows:

1. The bankruptcy court's July 14, 2021 opinion and order finding the Judgment in the New Jersey Action nondischargeable, with the exception of $57,605, is AFFIRMED.

2. The bankruptcy court's September 15, 2021 order denying Appellants' motion to stay pending appeal is AFFIRMED.

IT IS SO ORDERED.


Summaries of

Novartis Pharm. v. Adesanya

United States District Court, E.D. Pennsylvania
Nov 2, 2022
Civil Action 21-3402-KSM (E.D. Pa. Nov. 2, 2022)
Case details for

Novartis Pharm. v. Adesanya

Case Details

Full title:NOVARTIS PHARMACEUTICALS, Plaintiff/Appellee, v. ADENEKAN OLA-OLUWA…

Court:United States District Court, E.D. Pennsylvania

Date published: Nov 2, 2022

Citations

Civil Action 21-3402-KSM (E.D. Pa. Nov. 2, 2022)